Gene Therapy as a Novel Pharmaceutical Intervention for Stroke

被引:16
作者
Ooboshi, Hiroaki [1 ]
机构
[1] Fukuoka Dent Coll, Dept Med, Sect Internal Med, Fukuoka, Japan
关键词
Gene transfer; gene therapy; vector; brain; ischemia; stroke; neurogenesis; stem cell; FOCAL CEREBRAL-ISCHEMIA; PROTECTS STRIATAL NEURONS; MESENCHYMAL STEM-CELLS; NITRIC-OXIDE SYNTHASE; BLOOD-BRAIN-BARRIER; TISSUE-PLASMINOGEN ACTIVATOR; ENDOTHELIAL GROWTH-FACTOR; TRANSFER IN-VIVO; ARTERY OCCLUSION; SUBARACHNOID HEMORRHAGE;
D O I
10.2174/138161211795164149
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cerebrovascular disease is the leading cause of death and disability in Japan and most Western countries. Gene transfer techniques may be applicable to the treatment of serious types of stroke, since several experimental studies have revealed the usefulness of gene therapy in the protection of neurons, reduction of infarct size and improvement of function. Prevention of vasospasm after subarachnoid hemorrhage is one of the best candidates for vascular gene therapy. Ischemia-induced apoptosis, inflammation, and derangement of neurovascular units can be targeted by the gene transfer approach. Recent studies have shown that promotion of neurogenesis and functional recovery may also be achieved by this strategy. Furthermore, a combination of stem cell therapy with gene transfer methods may be feasible. This review describes novel approaches for the treatment of stroke using gene transfer techniques.
引用
收藏
页码:424 / 433
页数:10
相关论文
共 50 条
[21]   Pharmaceutical approach to somatic gene therapy [J].
Ledley, FD .
PHARMACEUTICAL RESEARCH, 1996, 13 (11) :1595-1614
[22]   The potential use of mesenchymal stem cells in stroke therapy-From bench to bedside [J].
Dulamea, Adriana Octaviana .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 352 (1-2) :1-11
[23]   Complement Cascade: New Avenues in Stroke Therapy [J].
Komotar, Ricardo J. ;
Starke, Robert M. ;
Arias, Eric J. ;
Garrett, Matthew C. ;
Otten, Marc L. ;
Merkow, Maxwell B. ;
Hassid, Benjamin ;
Mocco, J. ;
Sughrue, Michael E. ;
Kim, Grace H. ;
Mack, William J. ;
Ducruet, Andrew F. ;
Connolly, E. Sander .
CURRENT VASCULAR PHARMACOLOGY, 2009, 7 (03) :287-292
[24]   Cell-based therapy for ischemic stroke [J].
Zhang, Jing ;
Chopp, Michael .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (09) :1229-1240
[25]   Natalizumab: a new therapy for acute ischemic stroke? [J].
Simats, Alba ;
Garcia-Berrocoso, Teresa ;
Montaner, Joan .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (09) :1013-1021
[26]   Intra-arterial administration of cell-based biological agents for ischemic stroke therapy [J].
Spiliopoulos, Stavros ;
Festas, Georgios ;
Reppas, Lazaros ;
Brountzos, Elias .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (03) :249-259
[27]   Sequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke [J].
Soliman, Sahar ;
Ishrat, Tauheed ;
Fouda, Abdelrahman Y. ;
Patel, Ami ;
Pillai, Bindu ;
Fagan, Susan C. .
TRANSLATIONAL STROKE RESEARCH, 2015, 6 (04) :309-322
[28]   Excitotoxicity and stroke: Identifying novel targets for neuroprotection [J].
Lai, Ted Weita ;
Zhang, Shu ;
Wang, Yu Tian .
PROGRESS IN NEUROBIOLOGY, 2014, 115 :157-188
[29]   Gene therapy for cerebral arteries [J].
Ooboshi, H ;
Ibayashi, S .
MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA, 2003, 1252 :253-258
[30]   Future aspects of gene therapy in acute ischemic stroke [J].
Kitagawa, K ;
Hori, M ;
Matsumoto, M .
INTERNAL MEDICINE, 2005, 44 (04) :371-374